Stocks Health care CBDY
OTC · Health careTarget Group Inc. (CBDY)
Target Group Inc. brought in $3.5M of revenue over the twelve months to June 30, 2026, down 30.7% from a year earlier. It posted a net loss of $1.8M. At June 30, 2026 it held $14K in cash against $7.3M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.
Watch CBDY in 60 secondsWhat Target Group Inc. does
Target Group Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CBDY.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $3.9M | -$1.4M | -$0.00 | n/a |
| 2024 | $6.6M | $160.5K | $0.00 | n/a |
| 2023 | $3.7M | -$323.7K | -$0.00 | n/a |
| 2022 | $0 | -$4.5M | -$0.01 | n/a |
| 2021 | $0 | $272.9K | $0.00 | n/a |
| 2020 | $30K | -$7.1M | -$0.00 | -$1.5M |
Full financial statements: income, balance sheet and cash flow
Where CBDY ranks in Health care
Latest SEC filings
What Target Group Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 13, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 11% to $1.4M versus the same quarter last year; diluted EPS -$0.00 versus -$0.00.
- May 15, 2026Quarterly report 10-Q · period to March 31, 2026Revenue fell 37% to $879.4K versus the same quarter last year; diluted EPS -$0.00 versus -$0.00.
- March 31, 2026Annual report 10-K · period to December 31, 2025Revenue fell 41% to $3.9M versus the prior year; diluted EPS -$0.00 versus $0.00.
- November 7, 2025Quarterly report 10-Q · period to September 30, 2025Revenue fell 7.7% to $499.7K versus the same quarter last year; diluted EPS -$0.00 versus -$0.00.
- August 18, 2025New debt 8-K
- August 12, 2025
- May 9, 2025
- March 27, 2025Annual report 10-K · period to December 31, 2024Revenue rose 77% to $6.6M versus the prior year; diluted EPS $0.00 versus -$0.00.
- November 7, 2024
- August 26, 2024New debt 8-K
Questions about CBDY
What does Target Group Inc. do?
Target Group Inc. is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on OTC under the ticker CBDY.
Is Target Group Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $1.8M on revenue of $3.5M.
How much revenue does Target Group Inc. make?
Over the twelve months to June 30, 2026 Target Group Inc. reported revenue of $3.5M. That is 30.7% less than a year earlier.
When did Target Group Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026.
Similar companies
Compare CBDY with
Follow CBDY
Get an email when Target Group Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow CBDY: get an email when it filesWhere the numbers come from
Financial figures are the values Target Group Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.